AP
ABMD

Advisor Partners’s Abiomed Inc ABMD Stock Holding History

Advisor Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$324K Sell
1,310
-35
-3% -$9.45K 0.02% 609
2022
Q1 		$446K Buy
1,345
+124
+10% +$38.2K 0.03% 550
2021
Q4 		$439K Buy
1,221
+96
+9% +$32.4K 0.03% 548
2021
Q3 		$366K Sell
1,125
-47
-4% -$15.9K 0.02% 572
2021
Q2 		$366K Sell
1,172
-72
-6% -$22.1K 0.02% 593
2021
Q1 		$397K Buy
1,244
+2
+0.2% +$640 0.03% 549
2020
Q4 		$403K Buy
1,242
+4
+0.3% +$1.11K 0.03% 513
2020
Q3 		$343K Buy
1,238
+37
+3% +$10.7K 0.03% 493
2020
Q2 		$290K Buy
+1,201
New +$241K 0.03% 527
2019
Q2 		– Sell
-954
Closed -$272K – 676
2019
Q1 		$272K Sell
954
-168
-15% -$55.8K 0.03% 476
2018
Q4 		$365K Buy
1,122
+114
+11% +$39.6K 0.06% 355
2018
Q3 		$453K Sell
1,008
-49
-5% -$19.3K 0.06% 329
2018
Q2 		$432K Buy
1,057
+221
+26% +$80.1K 0.07% 319
2018
Q1 		$243K Sell
836
-79
-9% -$20K 0.05% 463
2017
Q4 		$209K Buy
+915
New +$171K 0.04% 530

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Advisor Partners's ABMD Position: Q2 2022 in Review

Advisor Partners reduced its Abiomed Inc (ABMD) stake by 2.6% in Q2 2022, selling an estimated $9.45K and leaving 1,310 shares worth $324K. The position accounts for 0.02% of the portfolio, ranked #609.

Advisor Partners first reported a position in ABMD in Q4 2017 and has held it in 15 quarters since. The position peaked at $453K in Q3 2018. 495 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Advisor Partners held 1,310 shares of Abiomed Inc worth $324K as of Q2 2022.
  • Advisor Partners sold 35 Abiomed Inc shares in Q2 2022, an estimated $9.45K.
  • Abiomed Inc made up 0.02% of Advisor Partners's portfolio in Q2 2022, its #609 holding.
  • Advisor Partners first reported a position in Abiomed Inc in Q4 2017 and has held it in 15 quarters since.
  • Advisor Partners's Abiomed Inc position peaked at $453K in Q3 2018.
  • 495 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.